Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis

Mehrdad Gholamzad ¹ , Hussein Baharlooi ² , Mehdi Shafiee Ardestani ³, Zeinab Seyedkhan ⁴, Maryam Azimi ⁵ *

Cited by CrossRef: 4

1- Scotland B, Shaw J, Dharmaraj S, Caprio N, Cottingham A, Joy Martín Lasola J, Sung J, Pearson R. Cell and biomaterial delivery strategies to induce immune tolerance. Advanced Drug Delivery Reviews. 2023;203:115141 [Crossref]

2- Gadhave D, Sugandhi V, Kokare C. Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis. Brain Research. 2024;1822:148674 [Crossref]

3- Lamparelli E, Marino M, Szychlinska M, Della Rocca N, Ciardulli M, Scala P, D'Auria R, Testa A, Viggiano A, Cappello F, Meccariello R, Della Porta G, Santoro A. The Other Side of Plastics: Bioplastic-Based Nanoparticles for Drug Delivery Systems in the Brain. Pharmaceutics. 2023;15(11):2549 [Crossref]

4- Rahiman N, Mohammadi M, Alavizadeh S, Arabi L, Badiee A, Jaafari M. Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis. Journal of Controlled Release. 2022;343:620 [Crossref]

5- Pinto M, Silva V, Barreiro S, Silva R, Remião F, Borges F, Fernandes C. Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform. Ageing Research Reviews. 2022;79:101658 [Crossref]

6- Horvath D, Basler M. PLGA Particles in Immunotherapy. Pharmaceutics. 2023;15(2):615 [Crossref]

7- Gu Z, Chen H, Zhao H, Yang W, Song Y, Li X, Wang Y, Du D, Liao H, Pan W, Li X, Gao Y, Han H, Tong Z. New insight into brain disease therapy: nanomedicines-crossing blood–brain barrier and extracellular space for drug delivery. Expert Opinion on Drug Delivery. 2022;19(12):1618 [Crossref]

8- Mwema A, Muccioli G, des Rieux A. Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis. Journal of Controlled Release. 2023;364:435 [Crossref]

9- Wright A, Nishiyama S, Han P, Kong P, Levy M. Administration methods and dosage of poly(lactic acid)-glycol intervention to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalitis mice. BMC Neurosci. 2024;25(1) [Crossref]